259 related articles for article (PubMed ID: 30209818)
1. Interim monitoring using the adaptively weighted log-rank test in clinical trials for survival outcomes.
Yang S
Stat Med; 2019 Feb; 38(4):601-612. PubMed ID: 30209818
[TBL] [Abstract][Full Text] [Related]
2. A unified approach to power and sample size determination for log-rank tests under proportional and nonproportional hazards.
Tang Y
Stat Methods Med Res; 2021 May; 30(5):1211-1234. PubMed ID: 33819109
[TBL] [Abstract][Full Text] [Related]
3. Improved logrank-type tests for survival data using adaptive weights.
Yang S; Prentice R
Biometrics; 2010 Mar; 66(1):30-8. PubMed ID: 19397582
[TBL] [Abstract][Full Text] [Related]
4. Comparison of survival distributions in clinical trials: A practical guidance.
Chen X; Wang X; Chen K; Zheng Y; Chappell RJ; Dey J
Clin Trials; 2020 Oct; 17(5):507-521. PubMed ID: 32594788
[TBL] [Abstract][Full Text] [Related]
5. Improving testing and description of treatment effect in clinical trials with survival outcomes.
Yang S
Stat Med; 2019 Feb; 38(4):530-544. PubMed ID: 29671899
[TBL] [Abstract][Full Text] [Related]
6. Sequential tests for non-proportional hazards data.
Brückner M; Brannath W
Lifetime Data Anal; 2017 Jul; 23(3):339-352. PubMed ID: 26969674
[TBL] [Abstract][Full Text] [Related]
7. A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes.
Yang S; Ambrosius WT; Fine LJ; Bress AP; Cushman WC; Raj DS; Rehman S; Tamariz L
Clin Trials; 2018 Jun; 15(3):305-312. PubMed ID: 29671345
[TBL] [Abstract][Full Text] [Related]
8. Robust group sequential designs for trials with survival endpoints and delayed response.
Ghosh P; Ristl R; König F; Posch M; Jennison C; Götte H; Schüler A; Mehta C
Biom J; 2022 Feb; 64(2):343-360. PubMed ID: 34935177
[TBL] [Abstract][Full Text] [Related]
9. Log-Rank Test vs MaxCombo and Difference in Restricted Mean Survival Time Tests for Comparing Survival Under Nonproportional Hazards in Immuno-oncology Trials: A Systematic Review and Meta-analysis.
Mukhopadhyay P; Ye J; Anderson KM; Roychoudhury S; Rubin EH; Halabi S; Chappell RJ
JAMA Oncol; 2022 Sep; 8(9):1294-1300. PubMed ID: 35862037
[TBL] [Abstract][Full Text] [Related]
10. On information fraction for Fleming-Harrington type weighted log-rank tests in a group-sequential clinical trial design.
Kundu MG; Sarkar J
Stat Med; 2021 May; 40(10):2321-2338. PubMed ID: 33624861
[TBL] [Abstract][Full Text] [Related]
11. A sample size formula for the supremum log-rank statistic.
Eng KH; Kosorok MR
Biometrics; 2005 Mar; 61(1):86-91. PubMed ID: 15737081
[TBL] [Abstract][Full Text] [Related]
12. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.
Horiguchi M; Hassett MJ; Uno H
Clin Trials; 2020 Dec; 17(6):597-606. PubMed ID: 32933339
[TBL] [Abstract][Full Text] [Related]
13. Partitioned log-rank tests for the overall homogeneity of hazard rate functions.
Liu Y; Yin G
Lifetime Data Anal; 2017 Jul; 23(3):400-425. PubMed ID: 26995734
[TBL] [Abstract][Full Text] [Related]
14. The efficiency of a weighed log-rank test under a percent error misspecification model for the log hazard ratio.
Zucker DM
Biometrics; 1992 Sep; 48(3):893-9. PubMed ID: 1420846
[TBL] [Abstract][Full Text] [Related]
15. Introducing a new estimator and test for the weighted all-cause hazard ratio.
Ozga AK; Rauch G
BMC Med Res Methodol; 2019 Jun; 19(1):118. PubMed ID: 31185922
[TBL] [Abstract][Full Text] [Related]
16. Sample size calculation for testing differences between cure rates with the optimal log-rank test.
Wu J
J Biopharm Stat; 2017; 27(1):124-134. PubMed ID: 26882262
[TBL] [Abstract][Full Text] [Related]
17. A novel sample size formula for the weighted log-rank test under the proportional hazards cure model.
Xiong X; Wu J
Pharm Stat; 2017 Jan; 16(1):87-94. PubMed ID: 27860138
[TBL] [Abstract][Full Text] [Related]
18. Interim analysis based on the weighted log-rank test for delayed treatment effects under staggered patient entry.
Yoshida M; Matsuyama Y
J Biopharm Stat; 2016; 26(5):842-58. PubMed ID: 26391147
[TBL] [Abstract][Full Text] [Related]
19. Combining stratified and unstratified log-rank tests in paired survival data.
Oakes D; Feng C
Stat Med; 2010 Jul; 29(16):1735-45. PubMed ID: 20572124
[TBL] [Abstract][Full Text] [Related]
20. Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations.
Eaton A; Therneau T; Le-Rademacher J
Clin Trials; 2020 Jun; 17(3):285-294. PubMed ID: 32063031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
